VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01253551
Recruitment Status : Completed
First Posted : December 3, 2010
Last Update Posted : October 16, 2012
Vertex Pharmaceuticals Incorporated
Information provided by (Responsible Party):
Tibotec BVBA

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : April 2011